|
NHLRC3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.760200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.074600E-01 |
| Normal-vs-Stage2 |
4.610600E-01 |
| Normal-vs-Stage3 |
3.276600E-01 |
| Normal-vs-Stage4 |
7.075800E-02 |
| Stage1-vs-Stage2 |
7.476200E-01 |
| Stage1-vs-Stage3 |
1.914150E-01 |
| Stage1-vs-Stage4 |
1.231830E-01 |
| Stage2-vs-Stage3 |
2.062200E-01 |
| Stage2-vs-Stage4 |
9.267900E-02 |
| Stage3-vs-Stage4 |
4.798400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.096600E-01 |
| Normal-vs-AfricanAmerican |
4.071000E-01 |
| Normal-vs-Asian |
3.670600E-01 |
| Caucasian-vs-AfricanAmerican |
7.324800E-01 |
| Caucasian-vs-Asian |
2.567000E-01 |
| AfricanAmerican-vs-Asian |
4.046400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.492400E-01 |
| Normal-vs-Female |
2.700200E-01 |
| Male-vs-Female |
4.823800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.688400E-01 |
| Normal-vs-Extreme_Weight |
2.861000E-01 |
| Normal-vs-Obese |
5.297400E-01 |
| Normal-vs-Extreme_Obese |
6.219800E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.162800E-01 |
| Normal_Weight-vs-Obese |
9.213000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.759200E-01 |
| Extreme_Weight-vs-Obese |
1.555040E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.354000E-01 |
| Obese-vs-Extreme_Obese |
7.454600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.609550E-01 |
| Normal-vs-Age(41-60Yrs) |
6.199800E-02 |
| Normal-vs-Age(61-80Yrs) |
6.259800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.913400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.455870E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.012800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.777000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.761240E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.424850E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.118600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.133500E-02 |
| Normal-VS-Type2 PRCC |
8.288800E-01 |
| Normal-VS-KIRP CIMP |
4.78439999840319E-08 |
| Normal-VS-Unclassified PRCC |
1.091380E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.624800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.40760000053331E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
4.389600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.95926999999596E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
2.921600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.10000000014865E-07 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.956200E-01 |
| Normal-vs-N1 |
6.242200E-01 |
| Normal-vs-N2 |
1.144080E-02 |
| N0-vs-N1 |
9.825200E-01 |
| N0-vs-N2 |
2.201200E-01 |
| N1-vs-N2 |
3.974200E-01 |
|
|
